You are on page 1of 3

Peritonitis

Nevoie afecta Diagnostic nursing Obiective Interventii autonome Interventii delegate Evaluare
risk for Infection Desired Independent Collaborative Infection Status
Outcomes/Evaluation Ziua 1 Ziua 1 Achieve timely healing, be free of
[septicemia]  Maintain sterile technique  Obtain specimens for purulent drainage or erythema, and
Risk Factors May Include Criteria—Client Will be afebrile.
when catheterizing client, culture and monitor results
Inadequate primary defenses— Infection Status provide of serial Risk Control
broken skin, traumatized tissue, Achieve timely healing, be free of Verbalize understanding of the
catheter care, and encourage blood, urine, and wound cultures.
altered peristalsis purulent drainage or erythema, and individual causative or risk factor(s)
be afebrile.
perineal cleansing on a  Assist with peritoneal
Inadequate secondary defenses— routine basis. aspiration, if indicated.
immunosuppression Risk Control
Verbalize understanding of the
 Monitor or restrict visitors  Administer antimicrobials, for
Invasive procedures and staff, as appropriate.
individual causative or risk factor(s) example, cephalosporins, such
Possibly Evidenced By Provide as cefotetan (Cefotan); extended
(Not applicable; presence of signs protective isolation if indicated. spectrum penicillins, such
and symptoms establishes an actual
 Perform and model good as piperacillin/tazobactam (Zosyn);
diagnosis)
hand-washing technique.  carbapenems, such as
Monitor meropenem (Merrem);
staff and client compliance with fluoroquinolones, such as nor
hand washing.  floxacin (Noroxin);
 Note individual risk factors: macrolides, such as
abdominal trauma, acute clindamycin
appendicitis, and peritoneal (Cleocin);
dialysis.  antifungals, such as
 Maintain strict aseptic metronidazole (Flagyl);
technique in caring for aminoglycosides, such as gentamicin
abdominal (Garamycin).
drains, incisions or open wounds,
dressings, and invasive
Ziua 2
sites. Cleanse with appropriate
solution.  Administer antimicrobials, for
example, cephalosporins, such
 Assess vital signs frequently, as cefotetan (Cefotan); extended
noting unresolved or
spectrum penicillins, such
progressing
as piperacillin/tazobactam (Zosyn);
hypotension, decreased pulse
pressure, tachycardia, fever,  carbapenems, such as
and tachypnea. meropenem (Merrem);
fluoroquinolones, such as nor
 Note changes in mental status,
such as new onset confusion  floxacin (Noroxin);
and stupor. macrolides, such as
clindamycin
 Note skin color, temperature, (Cleocin);
and moisture.
 antifungals, such as
 Monitor urine output. metronidazole (Flagyl);
aminoglycosides, such as gentamicin
 Observe drainage from (Garamycin)
wounds or drains.
Ziua 3
Ziua 2  Administer antimicrobials, for
 Assess vital signs frequently, example, cephalosporins, such
noting unresolved or as cefotetan (Cefotan); extended
progressing spectrum penicillins, such
hypotension, decreased pulse as piperacillin/tazobactam (Zosyn);
pressure, tachycardia, fever,  carbapenems, such as
and tachypnea. meropenem (Merrem);
 Note changes in mental status, fluoroquinolones, such as nor
such as new onset confusion  floxacin (Noroxin);
and stupor. macrolides, such as
 Note skin color, temperature, clindamycin
and moisture. (Cleocin);
 Monitor urine output.  antifungals, such as
metronidazole (Flagyl);
aminoglycosides, such as gentamicin
 Observe drainage from
(Garamycin)
wounds or drains.

Ziua 3
 Assess vital signs frequently,
noting unresolved or
progressing
hypotension, decreased pulse
pressure, tachycardia, fever,
and tachypnea.
 Note changes in mental status,
such as new onset confusion
and stupor.
 Note skin color, temperature,
and moisture.
 Monitor urine output.

 Observe drainage from


wounds or drains.

deficient Fluid Volume Desired Independent Collaborative Fluid Balance


Outcomes/Evaluation Monitor vital signs, noting presence Monitor laboratory studies: Hgb/Hct, Demonstrate improved fluid balance
May Be Related To
of hypotension (including electrolytes, protein, as evidenced by adequate urinary
Active fluid volume loss—vomiting; Criteria—Client Will postural changes), tachycardia, albumin, BUN, and creatinine (Cr). output with normal specific gravity,
medically restricted intake; Fluid Balance tachypnea, and fever. Administer plasma, blood, fluids, stable vital signs,
nasogastric (NG) or intestinal Demonstrate improved fluid balance Measure central venous pressure electrolytes, and diuretics, moist mucous membranes, good
aspiration as evidenced by adequate urinary (CVP) if available. as indicated. skin turgor, prompt capillary refill,
Failure of regulatory mechanisms— output with normal specific gravity, Maintain accurate intake and output Maintain NPO status with and weight within acceptable range.
fever, hypermetabolic state, fluid stable vital signs, (I&O) and correlate with nasogastric (NG) or intestinal
shifts from extracellular, moist mucous membranes, good skin daily weights. Include measured and aspiration.
intravascular, and interstitial turgor, prompt capillary refill, and estimated losses,
compartments into intestines and/or weight within acceptable range. such as with gastric suction, drains,
peritoneal space
dressings, Hemovacs,
Possibly Evidenced By diaphoresis, and abdominal girth for
Dry mucous membranes, decreased third spacing of fluid.
skin turgor, decreased pulse volume Measure urine specific gravity.
Decreased urinary output; increased Observe skin and mucous membrane
urine concentration dryness and turgor. Note
Hypotension; tachycardia peripheral and sacral edema.
Eliminate noxious sights or smells
from environment. Limit
intake of ice chips.
Change position frequently, provide
frequent skin care, and
maintain dry, wrinkle-free bedding.

acute Pain Desired Independent Collaborative Pain Control


Outcomes/Evaluation Note client’s age, developmental Administer medications, as Report pain is relieved or controlled.
May Be Related To
level, and current condition indicated, for example: Demonstrate use of relaxation skills
Chemical agent—irritation of the Criteria—Client Will (infant/child, critically ill, ventilated, Analgesics and opioids or other methods to promote
parietal peritoneum (toxins) Pain Control sedated, or cognitively Antiemetics, such as dolasetron comfort.
Physical agent—tissue trauma, Report pain is relieved or controlled. impaired). (Azemet), metoclopramide
accumulation of fluid in abdominal Demonstrate use of relaxation skills Investigate pain reports, noting (Reglan)
and peritoneal cavity (abdominal or other methods to promote location, duration, intensity Antipyretics, such as acetaminophen
distention) comfort. (0 to 10 [or similar] scale), and (Tylenol)
Possibly Evidenced By characteristics such as dull,
Verbalized/coded reports of pain sharp, or constant.
Guarding behavior; expressive Observe nonverbal cues and pain
behavior—restlessness, irritability behaviors (e.g., how client
Facial mask, self-focus holds body, facial expressions such
Changes in vital signs as grimacing, withdrawal,
narrowed focus, crying).
Maintain semi-Fowler’s position as
indicated.
Move client slowly and deliberately,
splinting painful area.
Provide comfort measures, such as
massage, back rubs, and
deep breathing. Instruct in relaxation
and visualization
exercises.
Provide frequent oral care. Remove
noxious environmental
stimuli.

risk for imbalanced Desired Independent Collaborative


Outcomes/Evaluation Auscultate bowel sounds, noting Monitor BUN, protein, prealbumin
Nutrition: less than absent and hyperactive or albumin, glucose, and
Criteria—Client Will
body Nutritional Status
sounds. nitrogen balance, as indicated.
Monitor NG tube output. Note Administer enteral or parenteral
requirements Maintain usual weight and positive presence of vomiting and feedings, as indicated.
Risk Factors May Include nitrogen balance diarrhea. Advance diet as tolerated—clear
Inability to ingest—nausea, vomiting Measure abdominal girth. liquids to soft food.
Inability to digest food/absorb Assess abdomen frequently for
nutrients—intestinal dysfunction, return to softness, reappear
metabolic abnormalities ance of normal bowel sounds, and
[Increased metabolic needs] passage of flatus.
Possibly Evidenced By Weigh regularly.
(Not applicable; presence of signs
and symptoms establishes an actual
diagnosis)

You might also like